Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators...

Post on 20-Jan-2018

213 views 0 download

description

Proportional effects on cause-specific mortality per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Transcript of Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators...

Number of participants with diabetes by trial

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Baseline characteristics of participants presenting with or without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Proportional effects on cause-specific mortality per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol in participants

with and without diabetes by history of vascular disease

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol by baseline prognostic factors in participants with diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol by baseline lipid profi le in participants with diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol, by year, in participants with and without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25